Literature DB >> 666628

Dysthyroid optic neuropathy. Clinical profile and rationale for management.

J D Trobe, J S Glaser, P Laflamme.   

Abstract

Dysthyroid optic neuropathy (DON) was diagnosed in 36 eyes of 21 patients with progressive visual loss and congestive ophthalmopathy. Systemic features in the patients with DON did not differ from those reported for Graves' disease patients except that patients with DON were older (mean age, 61 years) and did not show female preponderance. Congestive symptoms always preceded visual loss, which was gradual in onset and bilateral in most patients but acute and asymmetrical in several. Presenting acuities were poorer than 20/60 in 50% of cases; central scotomas, sometimes combined with inferior depression, were the predominant field defects. Congestive signs were of moderate intensity without severe proptosis or exposure keratopathy. Bilateral and symmetrical ductional restriction was the most common motility disturbance. Oral corticosteroids were effective in restoring visual function in ten of 21 eyes treated. Many steroid-unresponsive eyes were improved promptly by supervoltage orbital irradiation or surgical decompression. In general, therapeutic intervention appeared to hasten recovery and improve visual outcome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666628     DOI: 10.1001/archopht.1978.03910060033007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  38 in total

1.  Reversal of dysthyroid optic neuropathy following orbital fat decompression.

Authors:  M Kazim; S L Trokel; G Acaroglu; A Elliott
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Contrast sensitivity and the diagnosis dysthyroid optic neuropathy.

Authors:  M P Mourits; M S Suttorp-Schulten; R O Tijssen; P Apkarian
Journal:  Doc Ophthalmol       Date:  1990 Apr-Jul       Impact factor: 2.379

3.  Early diagnosis of Graves' optic neuropathy using visual evoked responses.

Authors:  J A Batch; F Lepre
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

4.  Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?

Authors:  Colin M Dayan; Margaret R Dayan
Journal:  Br J Ophthalmol       Date:  2007-04       Impact factor: 4.638

5.  Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.

Authors:  Kyung-Ah Park; Yoon-Duck Kim; Kyung In Woo; Changwon Kee; Jong Chul Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-12       Impact factor: 3.117

6.  Ophthaproblem. Thyroid-related eye disease.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1998-04       Impact factor: 3.275

7.  Retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after orbital decompression for dysthyroid optic neuropathy.

Authors:  Xinghua Wang; Fagang Jiang; Shengnan Cheng; Yueqi Yu; Yayan You; Jin Chen; Xiaohuan Pi
Journal:  Int Ophthalmol       Date:  2021-05-04       Impact factor: 2.031

8.  Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  Gennaro Ambrosio; Giuseppe Ferrara; Raffaella Vitale; Rocco De Marco
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

9.  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Authors:  R Ebner; M H Devoto; D Weil; M Bordaberry; C Mir; H Martinez; L Bonelli; H Niepomniszcze
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 10.  Graves' ophthalmopathy.

Authors:  W E Barrie
Journal:  West J Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.